Navigation Links
Pharmaron Expands Portfolio of Services with Acquisition of Bridge Laboratories China
Date:1/11/2010

IRVINE, Calif. and BEIJING, Jan. 11 /PRNewswire/ -- Pharmaron Holdings Limited, today announced it completed the acquisition of Bridge Laboratories China. Bridge Laboratories China is the leading contract research organization (CRO) in China providing western standard GLP-compliant toxicology services to pharmaceutical and biotech companies from around the world. With this acquisition, Pharmaron becomes the first integrated CRO in China supporting clients with drug discovery and development processes in support of IND filings. This strategic acquisition strengthens Pharmaron's leading position in the fast-growing, highly dynamic pharmaceutical CRO industry.

Bridge Laboratories China is the first CRO in China with western GLP-compliant preclinical toxicology service capabilities. It is the only preclinical CRO laboratory in China whose data have been accepted by both the FDA and EMEA as part of successful regulatory filings. The 84,000 square-foot, state-of-the-art facilities in Bridge Laboratories China include one of the largest and most sophisticated animal vivariums in China that is both AAALAC multi-species accredited and U.S. GLP-compliant.

"Pharmaron has built an exceptional team of scientists specialized in the areas of discovery and process chemistry, biology, DMPK, pharmacology and GMP manufacturing. The acquisition of Bridge Laboratories China enhances our drug R&D service capabilities by adding world-class expertise in western standard GLP-compliant toxicology and safety pharmacology to our diverse service portfolio," said Pharmaron Chairman and CEO Dr. Boliang Lou. "Pharmaron is now the first CRO in China to provide fully integrated drug discovery and development services, from discovery chemistry to IND filings."

"As a premier provider of drug discovery services, Pharmaron was an ideal partner given the company's diverse customer base of leading biotech and pharmaceutical companies," said Bridge Laboratories CEO Tom Oakley. "The addition of Bridge's U.S. GLP-compliant toxicology expertise will make Pharmaron the first company in China to provide truly integrated drug development services from discovery to IND."

About Pharmaron

Founded in 2003, Pharmaron is a leading pharmaceutical and biotechnology drug R&D CRO, with operations in China and the United States. Clients include pharmaceutical, biotechnology, academic and government organizations. As a research-driven and customer-focused company, Pharmaron provides a broad, integrated portfolio of laboratory and manufacturing services from drug discovery to IND submission. These services are designed to help its global partners improve the success of research and shorten the time of development cost effectively in discovering and developing drugs. For more information about Pharmaron, please visit http://www.pharmaron.com.


    CONTACTS:
    ---------
    Benjamin Navon                        Katherine Lee
    Schwartz Communications, Inc.         Pharmaron
    bnavon@schwartz-pr.com                klee@pharmaron.com
    (781) 684-0770                        562-686-9786



SOURCE Pharmaron Holdings Limited

RELATED LINKS
http://www.pharmaron.com

'/>"/>

SOURCE Pharmaron Holdings Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Masimo Expands its Irvine, California Corporate Headquarters to Accommodate Growth Projections
2. Shire Expands its Award-Winning ADHD Support Resource, ADHDSupport.com, by Launching an ADHD Twitter(TM) Page
3. Oxygen Biotherapeutics, Inc. Expands Board of Directors
4. Within3 Expands into Mobile Applications
5. Rib-X Pharmaceuticals Expands License Agreement with Yale University on New Ribosome Technology
6. Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers
7. Codexis Expands Collaboration with Teva
8. Stemline Therapeutics Expands Clinical Oncology Program Directed at Cancer Stem Cells With Addition of M.D. Anderson Cancer Center
9. Sarnova Expands Senior Management Team
10. Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16% as CMS Reimbursement Expands
11. Xanodyne Expands U.S. Sales Force and Launches Zipsor(TM) (diclofenac potassium) Liquid Filled Capsules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- The vast majority of dialysis patients currently receive ... usually 3 times a week, with treatment times averaging ... equipment preparation and wait time.  This regimen can be ... who are elderly and frail.  Many elderly dialysis patients ... for some duration of time. Residents in ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
(Date:6/23/2016)... -- The National Pharmaceutical Council (NPC) today announced that ... organization as its newest member.  ... and chief scientific officer, Mallinckrodt Pharmaceuticals, will serve ... of Directors. ... in support of our efforts to conduct research ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 27, 2016 , ... TherapySites, the leading website ... Tennessee Counseling Association. This new relationship allows TherapySites to continue to ... adding exclusive benefits and promotional offers. , "TCA is extremely excited about this ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, ... Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility ... home to some of the world’s leading providers of cereal and other breakfast foods. ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
Breaking Medicine News(10 mins):